The wait is finally over for applicants of the Sudeep Pharma IPO. The allotment status for the massive ₹895.00 crore public issue is today, Wednesday, 26 November 2025, following an overwhelming subscription response. Investors are now rushing to check their share allocation status, with the Grey Market Premium (GMP) signalling a robust listing gain on the horizon.
Investment Snapshot & Key Dates
The Sudeep Pharma IPO, a book-build issue, witnessed exceptional investor demand across all categories, leading to a strong oversubscription of 93.71 times.
- Total Issue Size: ₹895.00 crore
- Fresh Issue: ₹95.00 crore (0.16 crore shares)
- Offer for Sale (OFS): ₹800.00 crore (1.35 crore shares)
- Price Band: ₹563 to ₹593 per share
- Retail Lot Size: 25 shares (Minimum retail investment: ₹14,825 at the upper band)
- Allotment Date: Today, November 26, 2025
- Demat Credit/Refunds: November 27, 2025
- Listing Date (Tentative): November 28, 2025 on BSE and NSE (Mainboard IPO)
Source: RHP, Chittorgarh
Listing Hopes: GMP Signals Strong Premium
The excitement around the Sudeep Pharma IPO is amplified by a favourable trend in the unlisted market.
- Sudeep Pharma IPO GMP today is reportedly ₹97 per share, as of Nov 26, 2025 12:01 PM.
- Based on the final issue price of ₹593 (the upper band), this premium indicates an estimated listing price of ₹680 apiece.
- This projected price suggests an expected listing gain of nearly15% for allottees, solidifying its appeal within the domestic equity market.
Source: RHP, Chittorgarh
Step-by-Step: How to Check Sudeep Pharma Allotment Status Online
The basis of share allotment will be finalised by MUFG Intime India Pvt. Ltd., the official IPO registrar. Investors can check their Sudeep Pharma Allotment Status online via the registrar’s portal or the stock exchange websites.
Checking Status via Registrar (MUFG Intime India)
- Step 1: Visit the official MUFG Intime India IPO status page
- Step 2: Select ‘Sudeep Pharma Limited’ from the company dropdown menu
- Step 3: Choose one verification option: PAN / Application No. / DP ID / Account No.
- Step 4: Enter the corresponding details and click ‘Submit’
Checking Status via BSE
- Step 1: Go to the BSE application check page
- Step 2: Select ‘Equity’ in the issue type and choose ‘Sudeep Pharma Limited’ from the issue name list
- Step 3: Input either your Application No. or PAN
- Step 4: Complete the “I am not robot” verification and hit ‘Search’
Checking Status via NSE
- Step 1: Access the NSE allotment status page
- Step 2: Select ‘Equity and SME IPO bids’
- Step 3: Select ‘Sudeep Pharma Limited’ from the issue name list
- Step 4: Enter your PAN and Application Number, then click ‘Submit’
Source: BSE, NSE
Company Background: A Global Excipient Player
Sudeep Pharma Limited, established in 1989, is a key manufacturer of pharmaceutical excipients, food-grade minerals, and specialty nutrition ingredients. The company operates 6 manufacturing facilities with a combined annual production capacity of 50,000 MT.
It specialises in essential minerals like calcium, iron, magnesium, zinc, and sodium, supplying over 200 products to a diverse customer base in over 100 countries. The strong demand for the IPO reflects investor confidence in the high-entry-barrier, regulated specialty ingredients sector, which serves both the global pharma and food industries.
Source: RHP
The Bottomline
With the Sudeep Pharma Allotment Status expected today, all eyes are on the ₹680 estimated listing price. The overwhelming demand, coupled with the strong Sudeep Pharma IPO GMP, suggests a high probability of a listing pop on Friday, November 28, 2025.
Investors should proceed promptly with the online check process using the MUFG Intime or exchange portals to determine their share allocation and prepare for the upcoming BSE and NSE debut.
Disclaimer: Investments in the securities market are subject to market risks, read all the related documents carefully before investing. This content is purely for information purpose only and in no way to be considered as an advice or recommendation. The securities are quoted as an example and not as a recommendation.
Investors are requested to do their own due diligence before investing. Paytm Money Ltd SEBI Reg No. Broking – INZ000240532, Depository Participant – IN – DP – 416 – 2019, Depository Participant Number: CDSL – 12088800, NSE (90165), BSE (6707) Regd Office: 136, 1st Floor, Devika Tower, Nehru Place, Delhi – 110019. For complete Terms & Conditions and Disclaimers visit: https://www.paytmmoney.com/stocks/policies/terms .
